Global logistics project races to perfect precision therapy transport between Europe and US

Global logistics project races to perfect precision therapy transport between Europe and US

A pharmacy store with a vehicle parked in front, and a building in the left corner.

Global logistics project races to perfect precision therapy transport between Europe and US

A new logistics project is testing the safe and rapid transport of sensitive medical materials between Europe and the US. Since November 2025, cell and blood samples have been flown from Brussels to Dallas as part of the Precision Therapy Logistics Gateway (PTLG) initiative. The scheme aims to refine air cargo systems for handling precision therapies at a global scale.

The first test shipments under the PTLG project have already reached their destination. Brussels Airport, known for managing temperature-sensitive pharmaceuticals, is overseeing the process. Upon arrival there, each consignment clears customs before being stored in a climate-controlled area and loaded into refrigerated containers for the flight.

In Dallas, the materials are delivered to BioLabs Pegasus Park, where they undergo inspection. After checks, the samples are returned to Belgium. The project's goal is to pinpoint weaknesses in current logistics chains and adjust infrastructure to meet the strict demands of precision therapies—where stability, speed, and traceability are essential.

A total of 50 additional speed tests are planned to gather more data and confirm the system's reliability. These shipments will help establish a standardised framework for transporting such high-value medical cargo worldwide.

The successful completion of early speed tests marks a key step in developing a robust logistics network for precision therapies. With further trials underway, the PTLG project intends to create a repeatable model for international transport. This could set a benchmark for handling time-critical and temperature-sensitive medical shipments across borders.

Neueste Nachrichten